Open AccessQUALITY OF LIFE AFTER SURGICAL TREATMENT OF INSULIN-PRODUCTION TUMORS OF THE PANCREAS
Author(s) -
D V Lejinskiy,
Д В Лежинский,
А. В. Егоров,
А. В. Егоров,
Ivan Vasilyev,
И. А. Васильев,
Ivan Ivashov,
Ivan Ivashov,
A. Mironova,
A. Mironova
Publication year - 2019
Publication title -
vestnik rossijskoj voenno-medicinskoj akademii
Language(s) - English
Resource type - Journals
eISSN - 2687-1424
pISSN - 1682-7392
DOI - 10.17816/brmma13051
Subject(s) - enucleation , medicine , insulinoma , quality of life (healthcare) , insulin , pancreas , hypoglycemia , neuroendocrine tumors , surgery , resection , pancreatectomy , nursing
Background: insulinoma is a neuroendocrine tumor characterized by hyperproduction of insulin and hypoglycemia that decrease patient's quality of life. The only curative method of treatment is surgery. Aim: studying the quality of life of patients after various options for surgical treatment of insulin-producing pancreatic tumors. Materials and methods: 48 patients operated in the First Moscow State Medical University were included in the quality of life study. Patients were divided into two groups: those who underwent tumor enucleation (n 28), and patients who underwent resection of the pancreas (n 20). The study was performed using the questionnaire SF-36, not earlier than 3 months after surgery. Results: in the study of quality of life, a significant difference was only in a scale of role-physical functioning, which was higher in patients that underwent tumor enucleation, as opposed to patients after resection procedures. Conclusion: the quality of life in both groups remained at a high level; the differences were noted only in the scale of role-physical functioning, which was higher in patients after tumor enucleation.